Newcastle Disease Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Newcastle disease is a viral disease caused by avian paramyxovirus type 1 (APMV-1). The roots of this virus can be traced back to the genus Avulavirus, belonging to the Paramyxoviridae family. Newcastle disease virus (NDV) is a contagious bird disease, which affects various domestic birds such as chicken and turkey, among other birds. Chicken are found to be more susceptible to this disease. The viral strain can be classified into various phenotypes depending up on the virulence expression in chicken. These include least virulent strains, moderately virulent strains, which are also called mesogenic strains, and the most virulent strains also known as velogenic strains. The disease is transmitted by the fecal-oral route, owing to the exposure to the infected birds’ excretion, contaminated food, water, and equipment, among others. This disease is transmittable to humans.
The symptoms of the disease in birds vary based on the virus type, bird type, health and age of the bird, and environmental condition. The infected bird may show signs such as greenish diarrhea, breathing difficulties, sudden death, dropping wings, in-appetence, and sleepiness, among others. The virulent strains cause severe respiratory distress and nervous issues among the birds leading to high morbidity and mortality. The neurologic signs include tremors, torticollis (twisted neck), and paralysis. This high prevalence of the disease contributes to the significant growth of the Newcastle disease vaccine market.
The prevalence of the disease is expected to be significantly higher in the developing regions, leading to over 90% mortality in livestock. Increasing outbreaks of the disease, rising demand for livestock for consumption, and ongoing research to develop a treatment for this disease contribute to the growth of the market. However, the vaccines are known to deteriorate at room temperature within a couple of hours, making these unsuitable for transportation to distant villages. This is anticipated to restrain the Newcastle disease vaccines market. Lack of awareness about the disease among people maintaining livestock could also hamper market growth.
The global Newcastle disease vaccines market can be segmented based on vaccine type, species, end-user, and region. In terms of vaccine type, the market can be classified into live vaccines, killed vaccines, and thermostable vaccines. Eight different strains of the virus are used to make live vaccines, which include F, B1, LaSota, V4, V4-HR, I-2, Komarov, and Mukteswar. The thermostable vaccines segment is anticipated to record significant growth owing to its resistance to inactivation on exposure to high temperatures. Based on species, the market can be segmented into chicken, turkey, and others. In terms of end-user, the market can be divided into hospitals, veterinary clinics, and others. The veterinary clinics segment is anticipated to record significant growth in terms of revenue during the forecast period.
Geographically, the global Newcastle disease vaccines market can be segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to account for the largest market share, owing to growing awareness among people and ongoing research & development. Europe is projected to account for the second largest share. Asia Pacific is expected to expand at a high CAGR during the forecast period. This growth can be attributed to the significant contribution from emerging economies such as China and India. High prevalence of Newcastle disease in the region and growing dependence on poultry as a source of protein drive the Newcastle disease vaccines market in the region.
Leading players in the global Newcastle disease vaccines market include GALVmed, Boehringer Ingelheim, Hester Biosciences Limited, Ceva Animal Health LLC, Zoetis, Inc., Merck Animal Health, Elanco, CAVAC, and QYH Biotech.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017